References
1. Jo VY, Doyle LA. Refinements in sarcoma classification in the current 2013 world health organization classification of tumours of soft tissue and bone. Surg Oncol Clin North Am. 2016;25(4):621–43.
Choi H. Role of imaging in response assessment and individualised treatment for sarcomas. Clin Oncol. 2017; 29:481–8.
3. Stacchiotti S, Verderio P, Messina A, Morosi C, Collini P, Llombart-Bosch A, et al. Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer. 2012;118(23):5857–66.
4. Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, Tzeng CD, Chun YS, Feig BW, Vauthey JN, and Conrad C. Long-term survival according to histology and radiologic response to preoperative chemotherapy in 126 patients undergoing resection of non-GIST sarcoma liver metastases. Ann Surg Oncol. 2018;25(1):107–16
Therasse P, Le Cesne A, Van Glabbeke M, Verweij J, Judson I. RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma. Eur J Cancer. 2005;41(10):1426–30.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The author has no conflicts of interest to disclose.
Additional information
This ASO Author Reflections is a brief invited commentary on the article, Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases. Ann Surg Oncol. 2018;25:107–116.
Rights and permissions
About this article
Cite this article
Goumard, C., Conrad, C. ASO Author Reflections: Non-GIST Sarcoma Liver Metastasis: How to Use the Past and Present to Predict the Future. Ann Surg Oncol 25 (Suppl 3), 926–927 (2018). https://doi.org/10.1245/s10434-018-6835-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-6835-5